Home > HP (current issue) > News and features / News Centre | Search

PJ Online homeHospital Pharmacist
Vol 12 No 7 p245
July/August 2005

Hospital Pharmacist back issues

News summary


Medicines management review to be included in trust ratings

Medicines management will be assessed from a patient's perspective

Medicines management will be assessed from a patient’s perspective

Medicines management is to be the subject of review by the Healthcare Commission. It will be assessed along with diagnostic services and admissions management in the annual assessments (ratings) for trusts in England for 2005/6.

This review will follow on from the “A spoonful of sugar” report in 2001, the previous acute hospital portfolio review on medicines management 2001/2 and the 2003 Department of Health self-assessment framework. The aim will be to generate benchmarking data which will provide a direct comparison between trusts.

The framework on which the ratings for medicines management will be based is intended to identify areas for improvement and ascertain the drivers of good performance. The Healthcare Commission will consult widely with trusts and other bodies before making a final decision about which indicators these should be.

The review will investigate corporate governance structures supporting medicines management, including management of budgets and expenditure. Aspects such as clincal governance, evidence-based practice, modernisation of service delivery, patient experience and staff development will also be included.

The review consists of a core questionnaire using existing routine national data sources (eg, trust financial returns to the DoH and IMS health data). There will also be a medicines management mini-clinical audit, a clinical or ward team satisfaction survey and an outpatient waiting time audit.

The data collection will take place from September to mid November 2005 via a new web-based system with the national report and full benchmarking data to be published in May 2006.

Ray Fitzpatrick, clinical director, Royal Wolverhampton Hospitals NHS Trust and chair, Royal Pharmaceutical Society’s Hospital Pharmacists Group commented that “this high profile review by the Healthcare Commission will push medicines management up the corporate agenda. Trusts where medicines management is not performed at the right level will be highlighted and I hope this will help lead the development of medicines management services in those organisations.”

Back to Top


©The Pharmaceutical Journal